$Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease$

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease

Introduction: Current combined intensive chemotherapy and radiation regimens yield excellent survival rates in advanced classic Hodgkin’s lymphoma (cHL). However, acute toxicity in elderly, comorbid patients can be challenging and long-term survival in refractory patients remains poor.Patients and M...

Full description

Bibliographic Details
Main Authors:	Florian Lüke, Dennis C. Harrer, Karin Menhart, Daniel Wolff, Ernst Holler, Dirk Hellwig, Wolfgang Herr, Matthias Grube, Martin Vogelhuber, Albrecht Reichle, Daniel Heudobler
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Pharmacology
Subjects:	metronomic low dose chemotherapy everolimus piogliatazone etoricoxib anakoinosis r/r Hodkin's disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.599561/full

Similar Items

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy
by: Anna-Sophia Kattner, et al.
Published: (2020-04-01)

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML
by: Daniel Heudobler, et al.
Published: (2018-11-01)

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
by: Daniel Heudobler, et al.
Published: (2018-11-01)

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy
by: Florian Lüke, et al.
Published: (2021-06-01)

Metronomics: Intrinsic Anakoinosis Modulator?
by: André Nicolas, et al.
Published: (2018-06-01)

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
by: Albrecht Reichle, et al.
Published: (2020-09-01)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
by: Daniel Heudobler, et al.
Published: (2021-10-01)

A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
by: Daniel Heudobler, et al.
Published: (2021-03-01)

Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction
by: Daniel Heudobler, et al.
Published: (2019-12-01)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
by: Daniel Heudobler, et al.
Published: (2018-11-01)

Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01)

A Computational Model of Tumor Growth and Anakoinosis
by: Pan Pantziarka, et al.
Published: (2019-03-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)

DEVELOPMENT AND VALIDATION THE METHOD OF QUANTITATIVE DETERMINATION OF ETORICOXIB IN SOLID PHARMACEUTICAL FORMS BY HPLC
by: T. L. Batalova, et al.
Published: (2019-01-01)

Etoricoxib-induced pretibial erythema and edema
by: Pramod Kumar
Published: (2015-01-01)

Double-hit primary unilateral adrenal lymphoma with good outcome
by: Marković Olivera, et al.
Published: (2014-01-01)

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
by: Ke Wu, et al.
Published: (2019-08-01)

Outcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience
by: Avinash Pandey, et al.
Published: (2016-01-01)

Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01)

Pre-emptive 8 mg dexamethasone and 120 mg etoricoxib for pain prevention after periodontal surgery: A randomised controlled clinical trial
by: Kranti Konuganti, et al.
Published: (2015-01-01)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
by: Talita Máira Bueno da Silveira da Rocha, et al.

Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction
by: Emanuele Bruni, et al.
Published: (2018-11-01)

Audio stimulation athletes with visual impairments in running
by: Andrii Yefremenko, et al.
Published: (2021-04-01)

ETORICOXIB: THERAPEUTIC POTENTIAL
by: A. E. Karateev
Published: (2009-03-01)

Analgesia na entorse de tornozelo: estudo com etoricoxibe
by: Rogério Teixeira da Silva, et al.

Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials
by: Lin TM, et al.
Published: (2018-12-01)

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report
by: Dennis Christoph Harrer, et al.
Published: (2020-10-01)

Durable control of metastatic nasopharyngeal carcinoma with metronomic chemotherapy
by: Po-Hsiang Huang, et al.
Published: (2017-03-01)

Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
by: Ioannis Alagkiozidis, et al.
Published: (2015-04-01)

A case of wet purpura due to etoricoxib induced thrombocytopenia
by: Robin George Manappallil
Published: (2016-08-01)

Stability Study of Etoricoxib a Selective Cyclooxygenase-2 Inhibitor by a New Single and Rapid Reversed Phase HPLC Method
by: Muhammad Alzweiri, et al.
Published: (2018-07-01)

A simple Ultraviolet spectrophotometric method for the determination of etoricoxib in dosage formulations
by: Shipra Singh, et al.
Published: (2012-01-01)

Formulation Development, Statistical Optimization, In Vitro and In Vivo Evaluation of Etoricoxib-Loaded Eucalyptus Oil-Based Nanoemulgel for Topical Delivery
by: Nabil A. Alhakamy, et al.
Published: (2021-08-01)

Evaluation of chemopreventive response of two cycloxygenase-2 inhibitors, etoricoxib and diclofenac in rat colon cancer using FTIR and NMR spectroscopic techniques Evaluación de la respuesta quimiopreventiva de dos inhibidores de la ciclooxigenasa 2, etoricoxib y diclofenaco en el cáncer de colon murino empleando las técnicas espectroscópicas FTIR Y NMR
by: M. Kaur Saini, et al.
Published: (2010-08-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

Cardiovascular safety of etoricoxib
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

Perioperative Duloxetine and Etoricoxibto improve postoperative pain after lumbar Laminectomy: a randomized, double-blind, controlled study
by: Josef Zekry Attia, et al.
Published: (2017-12-01)

A case of toxic epidermal necrolysis probably due to etoricoxib
by: Sayanta Thakur, et al.
Published: (2019-01-01)

In vivo study of pro-inflammatory cytokine changes in serum and synovial fluid during treatment with celecoxib and etoricoxib and correlation with VAS pain change and synovial membrane penetration index in patients with inflammatory arthritis
by: Athina Theodoridou, et al.
Published: (2017-01-01)